Technology >> CEO Interviews >> October 5, 2000
DR. DANIEL L. KISNER, MD is President and Chief Executive Officer of
Caliper Technologies Corp. Dr. Kisner joined Caliper from Isis
Pharmaceuticals, where he was President and Chief Operating Officer. He
had previously been responsible for business development, product
development, and manufacturing as Executive Vice President. Prior to
joining Isis, Dr. Kisner was Division Vice President of Pharmaceutical
Development for Abbott Laboratories, where he led a team of 650
scientists, physicians and support personnel. His responsibilities
included the preclinical and clinical development of all Abbott
Laboratories' ethical pharmaceuticals. Dr. Kisner has also held the
position of Vice President of Clinical Research and Development for
International Studies for SmithKline Beecham and has a tenured position
in the Division of Oncology at The University of Texas, San Antonio
School of Medicine. Dr. Kisner is certified by the American Board of
Internal Medicine and certified in Medical Oncology. He is the author of
more than 50 scientific papers and 40 abstracts in clinical journals and
textbooks. Dr. Kisner received his MD from Georgetown University in
1972. Profile
Technologies Corporation?
Dr. Kisner: Caliper was founded in 1995. It is a microfluidic lab-on-a-
chip technology company
